ArticleFrontiers in medicine2026
Leakage-aware machine learning for data-driven performance prediction of metal-organic framework systems.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-organic frameworks (MOFs) are highly tunable porous materials whose performance is governed by complex interactions among structural, chemical, material, and operating variables. This study develops a leakage-aware, data-driven framework for predicting two distinct MOF performance endpoints: loading capacity and cell viability. The curated datasets comprised 161 loading-capacity observations described by 110 metal, ligand, functionality, and molecular-fingerprint variables, and 444 cell-viability observations described by 25 MOF, cell-category, and exposure variables. Histogram-based gradient boosting regression (HGBR) and partial least squares regression (PLSR) were optimized using differential evolution within five-fold grouped cross-validation. Exact duplicate records were constrained to the same data partition to prevent information leakage, while an additional source-held-out test was employed to assess transferability to publications not represented during model training. On the duplicate-safe 20% holdout, HGBR achieved the strongest predictive performance for cell viability (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.